2018年 PDUFA Fees and Program Invoice Update
Dear Colleague,
The PDUFA User Fee staff is currently finalizing the annual FY 2018 Program Fee invoices. We anticipate that invoices will be emailed by the last week of September 2017. If you do not receive your invoice by September 28, 2017, please contact PDUFA User Fee staff at CDERCollections@fda.hhs.gov.
The FY 2018 PDUFA fee rates were published in the Federal Register (FR) on September 14, 2017. The fee rates for FY 2018 are shown below:
PUFA User Fee Rate Types | FY 2018 |
Application Fee – Clinical Data Required | $2,421,495 |
Application Fee – No Clinical Data Required | $1,210,748 |
Program Fee | $304,162 |
For more information regarding the FY 2018 fee rates, please see the FR notice available at:
http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm152775.htm
—— 欢迎阅读近3个月内10,000+文章!——
它是当今一代名药,治愈了卡特总统,开创了重要的先河,却有着鲜为人知的艰辛往事!
划时代!FDA批准全球第一款CAR-T疗法!
肿瘤免疫疗法最新进展之理论篇:PD-1也许是前无古人,后无来者
《战狼2》中一箭封喉的毒素是什么?是否再次提醒我们一个新药研发的机会?
重磅 | 癌症,被重新定义!
10 : 0!完美数字!激动人心的历史时刻!热烈祝贺诺华在CAR-T领域代表人类迈出的一大步!
FDA推荐的仿制药开发机会!长长的名单!药时代强烈建议中国药企仔细研究,积极跟进,把握这一大好商机!
写在父亲节:我曾经能给绝症父亲最好的药物
谢雨礼博士 | CFDA最近的改革及其影响
FDA新局长的三把火:每个仿制药要有三家制造商!
划时代!FDA今日加速批准首款不区分肿瘤来源的抗癌疗法
Nat Methods:给我换个美女实验员!
FDA新局长Gottlieb博士对全员的第一次讲话。精彩!感人!
欢迎联系我们!drugtimes@qq.com